Latest

First Opinion Nancy Brown

Congress can prevent deaths from cardiac arrest if it acts now

First Opinion Muthu Alagappan, Rishi Khakhkhar, and Ben Kornitzer

STAT Plus: It’s time for a new medical specialty in asynchronous care

In the Lab Angus Chen

STAT Plus: Q&A: AI is coming for lots of jobs. What about that of the cancer researcher?

Health Helen Branswell

After a rocky debut for new RSV tools, hopes are high as a new season approaches

Insurance Tara Bannow and Bob Herman

STAT Plus: Medicare Advantage market expected to grow in 2025, despite big changes from insurers

Politics John Wilkerson

STAT Plus: Higher insurance costs eat into savings from drug pricing law by more than expected

Politics Rachel Cohrs Zhang and John Wilkerson

STAT Plus: JD Vance talked about reinsurance during the VP debate. How does it work?

Health Timmy Broderick

Scientists may have found the reason why people with schizophrenia hear voices

The Readout LOUD Adam Feuerstein, Allison DeAngelis, and Elaine Chen

STAT Plus: Biden’s health care AI czar, a new obesity company, and its dealmaking CEO

Business Bob Herman

STAT Plus: UnitedHealth sues Medicare to reverse downgraded star ratings

Health tech Mario Aguilar

STAT Plus: What Kaiser Permanente learned from using Apple Watch tech in Parkinson’s care

Health Tech Newsletter Mario Aguilar

STAT Plus: Hospital at Home: Medicare report shows how the experiment is going

The Readout Elaine Chen

STAT Plus: Dockworker strike puts drug supplies at risk

Adam's Take Adam Feuerstein

STAT Plus: Ron Renaud, biotech’s serial CEO, is ready for a new assignment — and maybe another deal?

First Opinion Westyn Branch-Elliman and Shira Doron

‘Institutional neutrality’ is the way to go for universities

Who to Know Timmy Broderick

STAT Plus: Brain-computer interfaces are rapidly evolving. Here are six scientists shaping the field

Exclusive Lev Facher

To aid addiction treatment, lawmakers tell DEA to back off buprenorphine enforcement

Health tech Brittany Trang

STAT Plus: Epic and Particle dragged a nonprofit into their antitrust fight. Here’s what you need to know

First Opinion Jane Martin

Louisiana’s new mifepristone and misoprostol law puts my patients at unnecessary risk

Health Helen Branswell

Was Missouri’s bird flu case a one-off or something more? Quest for answers faces testing delay

Health tech Mario Aguilar

STAT Plus: ResMed CEO on how wearables, GLP-1s will impact sleep apnea device sales

Pharmalot Ed Silverman

STAT Plus: Lawmakers want FTC to probe big PBMs over private-label biosimilar deals

In the Lab Anil Oza

Why a map of a fruit fly’s brain has neuroscientists ‘blown away’

Breaking News Bob Herman

STAT Plus: Humana tumbles as insurer faces $3 billion hit to revenue over lower Medicare star ratings

Pharmalot Ed Silverman

STAT Plus: Gilead strikes voluntary licensing deals in poor countries for its pricey HIV drug

First Opinion Torie Bosch

How the 2024 election gets mental health right — and wrong

First Opinion Sandeep Jauhar and Maria Avila

When should marijuana use deny a patient an organ transplant?

Biotech Adam Feuerstein

STAT Plus: The biotech scorecard for the fourth quarter: 14 stock-moving events to watch

Exclusive Lev Facher

STAT Plus: Key lawmakers pressure Biden to preserve telehealth prescribing of effective addiction treatment